Michael Kauffman, Chief Executive Officer at Karyopharm Therapeutics Inc. (KPTI), sold 37,313 shares at $19.19 ($378K) on 2020-01-09, disclosed to the SEC on 2020-01-10.
Open-market sale of $378k KPTI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 17,313 | $0 | 0.0% |
| 2 | $18.57 | 10,000 | $186K | 49.2% |
| 3 | $19.19 | 10,000 | $192K | 50.8% |
| Total | $10.12 avg | 37,313 | $378K | 100% |
| Filing → |
| KPTI | SELL | 2022-03-02 | $128K | — | Filing → |
| KPTI | SELL | 2022-02-22 | $440K | — | Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |